Literature DB >> 11905459

Emerging pathways in colorectal-cancer development.

Andrew M M Haydon1, Jeremy R Jass.   

Abstract

The past decade has seen the emergence of new pathways in the development of colorectal cancer. There is now clear evidence that subsets of these tumours do not show chromosomal instability and do not follow the suppressor pathway. Instead, about 15% of colorectal cancers are characterised by microsatellite instability (MSI). This feature arises through defective DNA mismatch repair, which is related either to a germline mutation (as in hereditary non-polyposis colorectal carcinoma) or to failure to express a mismatch-repair gene. CpG-island methylation has been linked to sporadic cancers with a high frequency of MSI. This type of methylation leads to loss of gene expression when it occurs in the promoter region of a gene. Tumours may have high or low type C (cancer-related) CpG-island methylation. When methylation affects hMLH1 (mismatch repair gene), the resultant cancer has high MSI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11905459     DOI: 10.1016/s1470-2045(02)00649-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  37 in total

1.  Smoking and the association of advanced colorectal neoplasia in an asymptomatic average risk population: analysis of exposure and anatomical location in men and women.

Authors:  Joseph C Anderson; Koorosh Moezardalan; Catherine R Messina; Michael Latreille; Robert D Shaw
Journal:  Dig Dis Sci       Date:  2011-07-13       Impact factor: 3.199

2.  Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers.

Authors:  Guoxiang Cai; Ye Xu; Hongfen Lu; Yingqiang Shi; Peng Lian; Junjie Peng; Xiang Du; Xiaoyan Zhou; Zuqing Guan; Daren Shi; Sanjun Cai
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

3.  Poorly differentiated adenocarcinoma of the colon: subsite location and clinicopathologic features.

Authors:  Yasuo Imai
Journal:  Int J Colorectal Dis       Date:  2014-11-23       Impact factor: 2.571

4.  Mismatch repair protein expression in patients with stage II and III sporadic colorectal cancer.

Authors:  Lihua Zhao
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

5.  Preferences for genetic testing for colorectal cancer within a population-based screening program: a discrete choice experiment.

Authors:  Jorien Veldwijk; Mattijs S Lambooij; Frank G J Kallenberg; Henk J van Kranen; Annelien L Bredenoord; Evelien Dekker; Henriëtte A Smit; G Ardine de Wit
Journal:  Eur J Hum Genet       Date:  2015-06-03       Impact factor: 4.246

6.  Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status.

Authors:  Akiko Hanyuda; Yin Cao; Tsuyoshi Hamada; Jonathan A Nowak; Zhi Rong Qian; Yohei Masugi; Annacarolina da Silva; Li Liu; Keisuke Kosumi; Thing Rinda Soong; Iny Jhun; Kana Wu; Xuehong Zhang; Mingyang Song; Jeffrey A Meyerhardt; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Shuji Ogino; Reiko Nishihara
Journal:  Eur J Epidemiol       Date:  2017-05-16       Impact factor: 8.082

7.  Aberrant CpG island methylation in early-onset sporadic gastric carcinoma.

Authors:  Hee Cheol Kim; Jin Cheon Kim; Sun Ae Roh; Chang Sik Yu; Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim; Kun Choon Park; Rin Chang
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

8.  Survival after colorectal cancer diagnosis is associated with colorectal cancer family history.

Authors:  Jason A Zell; Jane Honda; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer.

Authors:  Seung Tae Kim; Jeeyun Lee; Se Hoon Park; Joon Oh Park; Ho Yeong Lim; Won Ki Kang; Jin Yong Kim; Young Ho Kim; Dong Kyung Chang; Poong-Lyul Rhee; Dae Shick Kim; Haeran Yun; Yong Beom Cho; Hee Cheol Kim; Seong Hyeon Yun; Ho-Kyung Chun; Woo Yong Lee; Young Suk Park
Journal:  Med Oncol       Date:  2009-12-01       Impact factor: 3.064

Review 10.  First-line treatment strategies to improve survival in patients with advanced colorectal cancer.

Authors:  Sharlene Gill; Richard M Goldberg
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.